These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

634 related articles for article (PubMed ID: 16754881)

  • 21. Array comparative genomic hybridization and its applications in cancer.
    Pinkel D; Albertson DG
    Nat Genet; 2005 Jun; 37 Suppl():S11-7. PubMed ID: 15920524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Array-based comparative genomic hybridization for genome-wide screening of DNA copy number in bladder tumors.
    Veltman JA; Fridlyand J; Pejavar S; Olshen AB; Korkola JE; DeVries S; Carroll P; Kuo WL; Pinkel D; Albertson D; Cordon-Cardo C; Jain AN; Waldman FM
    Cancer Res; 2003 Jun; 63(11):2872-80. PubMed ID: 12782593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA copy number alterations and expression of relevant genes in triple-negative breast cancer.
    Han W; Jung EM; Cho J; Lee JW; Hwang KT; Yang SJ; Kang JJ; Bae JY; Jeon YK; Park IA; Nicolau M; Jeffrey SS; Noh DY
    Genes Chromosomes Cancer; 2008 Jun; 47(6):490-9. PubMed ID: 18314908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Array comparative genomic hybridization copy number profiling: a new tool for translational research in solid malignancies.
    Costa JL; Meijer G; Ylstra B; Caldas C
    Semin Radiat Oncol; 2008 Apr; 18(2):98-104. PubMed ID: 18314064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sequence variations of microRNAs in human cancer: alterations in predicted secondary structure do not affect processing.
    Diederichs S; Haber DA
    Cancer Res; 2006 Jun; 66(12):6097-104. PubMed ID: 16778182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genomic and epigenomic cross-talks in the regulatory landscape of miRNAs in breast cancer.
    Samantarrai D; Dash S; Chhetri B; Mallick B
    Mol Cancer Res; 2013 Apr; 11(4):315-28. PubMed ID: 23360796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genomic alterations as mediators of miRNA dysregulation in ovarian cancer.
    Kan CW; Howell VM; Hahn MA; Marsh DJ
    Genes Chromosomes Cancer; 2015 Jan; 54(1):1-19. PubMed ID: 25280227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Landscape of somatic allelic imbalances and copy number alterations in human lung carcinoma.
    Staaf J; Isaksson S; Karlsson A; Jönsson M; Johansson L; Jönsson P; Botling J; Micke P; Baldetorp B; Planck M
    Int J Cancer; 2013 May; 132(9):2020-31. PubMed ID: 23023297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-resolution analysis of DNA copy number alterations and gene expression in renal clear cell carcinoma.
    Yoshimoto T; Matsuura K; Karnan S; Tagawa H; Nakada C; Tanigawa M; Tsukamoto Y; Uchida T; Kashima K; Akizuki S; Takeuchi I; Sato F; Mimata H; Seto M; Moriyama M
    J Pathol; 2007 Dec; 213(4):392-401. PubMed ID: 17922474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prioritizing breast cancer subtype related miRNAs using miRNA-mRNA dysregulated relationships extracted from their dual expression profiling.
    Hua L; Zhou P; Li L; Liu H; Yang Z
    J Theor Biol; 2013 Aug; 331():1-11. PubMed ID: 23619378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA and gene expression analysis of melatonin-exposed human breast cancer cell lines indicating involvement of the anticancer effect.
    Lee SE; Kim SJ; Youn JP; Hwang SY; Park CS; Park YS
    J Pineal Res; 2011 Oct; 51(3):345-52. PubMed ID: 21615491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-resolution gene copy number and expression profiling of human chromosome 22 in ovarian carcinomas.
    Benetkiewicz M; Wang Y; Schaner M; Wang P; Mantripragada KK; Buckley PG; Kristensen G; Børresen-Dale AL; Dumanski JP
    Genes Chromosomes Cancer; 2005 Mar; 42(3):228-37. PubMed ID: 15578687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High copy number variation of cancer-related microRNA genes and frequent amplification of DICER1 and DROSHA in lung cancer.
    Czubak K; Lewandowska MA; Klonowska K; Roszkowski K; Kowalewski J; Figlerowicz M; Kozlowski P
    Oncotarget; 2015 Sep; 6(27):23399-416. PubMed ID: 26156018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of DNA amplification on gene expression patterns in breast cancer.
    Hyman E; Kauraniemi P; Hautaniemi S; Wolf M; Mousses S; Rozenblum E; Ringnér M; Sauter G; Monni O; Elkahloun A; Kallioniemi OP; Kallioniemi A
    Cancer Res; 2002 Nov; 62(21):6240-5. PubMed ID: 12414653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. No Evidence that MicroRNAs Coevolve with Genes Located in Copy Number Regions.
    Jovelin R
    Mol Biol Evol; 2015 Jul; 32(7):1890-4. PubMed ID: 25804521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Profiling breast cancer by array CGH.
    Albertson DG
    Breast Cancer Res Treat; 2003 Apr; 78(3):289-98. PubMed ID: 12755488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sub-megabase resolution tiling (SMRT) array-based comparative genomic hybridization profiling reveals novel gains and losses of chromosomal regions in Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma cell lines.
    Fadlelmola FM; Zhou M; de Leeuw RJ; Dosanjh NS; Harmer K; Huntsman D; Lam WL; Banerjee D
    Mol Cancer; 2008 Jan; 7():2. PubMed ID: 18179710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined array comparative genomic hybridization and tissue microarray analysis suggest PAK1 at 11q13.5-q14 as a critical oncogene target in ovarian carcinoma.
    Schraml P; Schwerdtfeger G; Burkhalter F; Raggi A; Schmidt D; Ruffalo T; King W; Wilber K; Mihatsch MJ; Moch H
    Am J Pathol; 2003 Sep; 163(3):985-92. PubMed ID: 12937139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integration of DNA copy number alterations and prognostic gene expression signatures in breast cancer patients.
    Horlings HM; Lai C; Nuyten DS; Halfwerk H; Kristel P; van Beers E; Joosse SA; Klijn C; Nederlof PM; Reinders MJ; Wessels LF; van de Vijver MJ
    Clin Cancer Res; 2010 Jan; 16(2):651-63. PubMed ID: 20068109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of DNA copy number changes in microdissected serous ovarian cancer tissue using a cDNA microarray platform.
    Tsuda H; Birrer MJ; Ito YM; Ohashi Y; Lin M; Lee C; Wong WH; Rao PH; Lau CC; Berkowitz RS; Wong KK; Mok SC
    Cancer Genet Cytogenet; 2004 Dec; 155(2):97-107. PubMed ID: 15571795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.